Just In
Monoclonal Antibody Improves Survival in Melanoma
Patients who received ipilimumab lived nearly four months longer than those who received an alternative experimental vaccine that previously showed activity against melanoma. The median survival was 10.1 months for ipilimumab versus 6.4 months for the vaccine.
CTCs May Help Diagnose Early-Stage Prostate Cancer
Researchers have isolated tumor cells circulating in the blood of patients with localized and advanced prostate cancer. The researchers were able to identify genetic changes in the circulating tumor cells (CTCs), which they hope is a step forward in using CTCs to guide treatment decisions and improve patient care.
Single Dose of Radiation Effective for Breast Cancer
A single dose of radiation during surgery is just as effective as a prolonged course of radiotherapy for breast cancer, a new study suggests. The study investigated using a single shot of radiotherapy to a tumor site in more than 2,000 women with invasive ductal breast carcinoma undergoing breast-conserving surgery.
Gefitinib May Improve Progression-Free Survival From Lung Cancer
A recent study found that the response and progression-free survival rates of patients with newly diagnosed metastatic non-small cell lung cancer who had received gefitinib was significantly higher than patients who had received carboplatin plus paclitacel (73.7% versus 30.7% and 10.8 months versus 5.4 months, respectively).
Yoga Improves Fatigue and Quality of Life
The largest randomized, controlled study to date examining the role of a yoga program for cancer survivors has found that a four-week program helped them sleep better, experience less fatigue, and improve their quality of life.
Loading ...